Back to Results
First PageMeta Content
Argen / Autoimmunity / Autoantibody / Anti-SSA/Ro autoantibodies / Systemic lupus erythematosus / Myasthenia gravis / Anatomy / Autoimmune diseases / Biology


arGEN-X raises EUR 5 million from PMV in extension of EUR 32.5 million series B Funds to advance ARGX-113, a novel antibody fragment approach to promote degradation and clearance of disease-causing autoantibodies, toward
Add to Reading List

Document Date: 2013-11-04 05:32:28


Open Document

File Size: 79,72 KB

Share Result on Facebook
UPDATE